Latest news

26/07/2019

Precision medicine and transgene T cells: 6th Munich Cancer Retreat in Herrsching am Ammersee

„An exciting overview over the field of precision oncology” was given by Christophe Le Tourneau, lead of landmark trials such as SHIVA 01 and 02 as mentioned by Michael von Bergwelt (deputy…

18/07/2019

Making cancer stem cells visible to the immune system - New results may enable innovative treatment concept against leukemia

Joint press release of the German Cancer Research Center (DKFZ), the German Cancer Consortium (DKTK), and the University Hospital Tübingen. Leukemia stem cells protect themselves against the immune…

24/06/2019

Focus on BAP1 for the diagnosis and therapy of kidney cancer and uveal melanoma

Introducing Samuel Peña-Llopis at DKTK Essen/Düsseldorf Samuel Peña-Llopis is leading the new young investigator group for Translational Genomics in Solid Tumors at the partner site Essen/Düsseldorf…

13/06/2019

Not silent at all

The so-called "silent" or "synonymous" genetic alterations do not result in altered proteins. But they can nevertheless influence numerous functions of the cell and thus also disease processes.…

05/06/2019

Stomach and colorectal cancer: Identifying patients at an early stage who are suitable for artificial intelligence immunotherapy.

Press release of the NCT Heidelberg. Changes in certain sections of the genetic material of cancer cells, so-called microsatellites, can provide an important indication of whether immunotherapy…

29/04/2019

Fighting colon cancer with killer cells

Genetically modified immune cells can successfully destroy colon cancer cells. This has been demonstrated for the first time by scientists from the German Cancer Consortium (DKTK) at Georg Speyer…

11/04/2019

Targeted approach to therapy for rare type of bone cancer

Press release by NCT Heidelberg. Chordomas are rare bone tumors for which only few options of treatment exist. Scientists and doctors from the National Center for Tumor Diseases (NCT), the German…

04/04/2019

UA Ruhr Researchers Jointly Develop Basis for Targeted Cancer Therapy

Press release of the TU Dortmund. From basic research to application – the way to drug discovery is long. Scientists from TU Dortmund University, the Medical Faculty of the University of…

03/04/2019

Our medicine is research

The aim of SYNERGIE, the new magazine published jointly by the German Centers of Health Research (DZG,) is to present modern medical research and provide a brief digest of the latest research…

25/03/2019

Cancer research must have a social impact – A new strategy concept for Europe

Curing cancer is one of five key focus areas of Horizon Europe, the new European framework program for research and innovation. This was decided by the Competetiveness Council of the European Union in…

21/03/2019

The evolution of brain tumors

Scientists from the German Cancer Research Center and German Cancer Consortium (DKTK) found in a recent study that only three different genetic alterations drive the early development of malignant…

21/02/2019

Colon cancer: Different Wnt signaling pathways lead colon cells astray

Signaling molecules in the Wnt family are some of the most essential messengers for continuous regeneration of our stressed colon mucosa. At the same time, “too much” Wnt is a frequent trigger for…

31/01/2019

Psychiatric drug as a new treatment for leukemia

A new kind of leukemia treatment using an antidepressant could offer a new option to patients who are resistant to current therapies. German Cancer Consortium (DKTK) scientists working at the…

28/01/2019

New biomarker to monitor skin cancer therapies

Press release of UDE/University Hospital Essen Merkel cell carcinoma is a rare but highly aggressive form of skin cancer that is triggered by a virus or by UV light. A biomarker that can monitor the…

31/12/2018

EMBO Young Investigator Award for Hind Medyouf

Dr. Hind Medyouf, a DKTK faculty member at the Frankfurt site and a group leader at the Institute for Tumor Biology and Experimental Therapy and the Frankfurt Cancer Institute, has been awarded the…

20/12/2018

DKTK says thank you and Merry Christmas!

We look forward to further projects with our physicians, scientists, partners and supporters to fight cancer!

19/12/2018

Nature publication reports first-in-human trial of a novel actively personalized therapeutic vaccine for brain cancer

Press Release by Glioma Actively Personalized Vaccine Consortium (GAPVAC) The prospect of an actively personalized approach to the treatment of glioblastoma has moved a step closer with the recent…

12/12/2018

High distinction for stem cell researcher Andreas Trumpp

This year's State Research Prize of Baden-Württemberg awarded for outstanding achievements in applied research goes to Andreas Trumpp from the German Cancer Research Center (DKFZ), German Cancer…

10/12/2018

The sleeping beauty among brain tumors

Press release by KiTZ Scientists from the Hopp Children's Tumor Center Heidelberg (KiTZ), together with two other teams from the German Cancer Association (DKTK) and researchers from the UK, have…

05/12/2018

NCT/DKTK-MASTER: Cancer genome analysis nearing clinical application

Press Release of the NCT Heidelberg Scientists today are able to observe tumor cells in increasing detail and thus gain a better understanding of how cancer cells differ from healthy ones. Doctors…